Mark Jerome Pykett - Net Worth and Insider Trading

Mark Jerome Pykett Net Worth

The estimated net worth of Mark Jerome Pykett is at least $519 dollars as of 2024-05-02. Mark Jerome Pykett is the CEO of Navidea Biopharmaceuticals Inc and owns about 14,831 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $519. Details can be seen in Mark Jerome Pykett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark Jerome Pykett has not made any transactions after 2014-05-09 and currently still holds the listed stock(s).

Transaction Summary of Mark Jerome Pykett

To

Mark Jerome Pykett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Jerome Pykett owns 3 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) , Savara Inc (SVRA) , and Alseres Pharmaceuticals Inc (ALSE) .

Click here to see the complete history of Mark Jerome Pykett’s form 4 insider trades.

Insider Ownership Summary of Mark Jerome Pykett

Ticker Comapny Transaction Date Type of Owner
NAVB Navidea Biopharmaceuticals Inc 2014-05-09 EVP
SVRA Savara Inc 2004-01-29 director
ALSE Alseres Pharmaceuticals Inc 2009-01-14 President and COO

Mark Jerome Pykett Latest Holdings Summary

Mark Jerome Pykett currently owns a total of 1 stock. Mark Jerome Pykett owns 14,831 shares of Navidea Biopharmaceuticals Inc (NAVB) as of May 9, 2014, with a value of $519.

Latest Holdings of Mark Jerome Pykett

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NAVB Navidea Biopharmaceuticals Inc 2014-05-09 14,831 0.04 519

Holding Weightings of Mark Jerome Pykett


Mark Jerome Pykett Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Jerome Pykett has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 500 shares on May 9, 2014, which cost Mark Jerome Pykett around $13,400.

Insider Trading History of Mark Jerome Pykett

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Jerome Pykett Trading Performance

GuruFocus tracks the stock performance after each of Mark Jerome Pykett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Jerome Pykett is -0.77%. GuruFocus also compares Mark Jerome Pykett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Jerome Pykett within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark Jerome Pykett's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark Jerome Pykett

Average Return

Average return per transaction

Outperforming Transactions

2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 10.08
Relative Return to S&P 500(%) 8.93

Mark Jerome Pykett Ownership Network

Ownership Network List of Mark Jerome Pykett

No Data

Ownership Network Relation of Mark Jerome Pykett


Mark Jerome Pykett Owned Company Details

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

Mark Jerome Pykett is the EVP of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

Mark Jerome Pykett Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Jerome Pykett. You might contact Mark Jerome Pykett via mailing address: 223a Main St, Boxford Ma 021921.

Discussions on Mark Jerome Pykett

No discussions yet.